Y10S 530/848
Lungs
Y10S530/848 (Lungs) appears on 28 US grants and 3 published applications in this corpus.
Search patents in Y10S- Granted patents
- 28
- Published applications
- 3
- Assignees
- 20
- Inventors
- 54
- Latest grant
- 3 Jul 2001
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions3 Jul 2001US 6,255,281 B1Claragen, Inc. and U.S. Government
- Human phospholipid binding proteins16 May 2000US 6,063,767 AIncyte Pharmaceuticals, Inc.
- Human phospholipid binding proteins30 Mar 1999US 5,888,742 AIncyte Pharmaceuticals, Inc.
- Nerve growth induction, stimulation and maintenance and enzyme potentiation9 Sep 1997US 5,665,706 AEast Carolina University
- Neurotrophic factor15 Aug 1995US 5,441,937 AHouston Biotechnology Incorporated
- Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions13 Mar 2008US 2008/0064633 A1
- Human phospholipid binding proteins26 Jun 2003US 2003/0119730 A1Incyte Pharmaceuticals, Inc.
- Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions21 Nov 2002US 2002/0173460 A1Claragen, Inc.
Most cited
By later US patents
- Controlled release formulations of trophic factors in ganglioside-lipsome vehicle653US 5,073,543 AG. D. Searle & Co. · 1991
- Human squamous lung carcinoma cell specific antigens and antibodies60US 5,019,497 A1991
- Neurotrophic factor40US 5,166,317 AHouston Biotechnology Incorporated · 1992
- Process for recovering interferon31US 4,343,736 AThe Green Cross Corporation · 1982
- Method for the identification and purification of human lung tumor-associated antigens (hLTAA) and clinical detection and determination of these antigens28US 4,514,506 AThe Government of the United States as represented by the Secretary of the Department of Health and Human Services · 1985